Media & Analysis

News
David Munis Zepernick

David Munis Zepernick

Head of Business Development and Public Affairs

Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.

MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.

If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.

Capital injection for Danish-Swedish diabetes research

Sweden and Denmark are among the countries in the world hardest hit by type 1 diabetes. The DiaUnion project now receives an additional EUR 1 million funding to investigate the link between type 1 diabetes and related autoimmune diseases.    Type 1 diabetes causes the immune system to attack and destroy the body’s own vital insulin-producing cells. The disease is chronic and typically affects children and adolescents. In Sweden, about 50,000 people live with type 1 diabetes, and the situation...

Life science in Skåne is doing good

If you want to know exactly how good, please download the survey published and presented today at Malmoe City Hall by ØresundsInstituttet and Medicon Valley Alliance. Skåne is increasingly becoming the bridge between Danish and Swedish life science and a force to be reckoned when dealing with national life science strategies in both countries. The survey is co-funded by Interreg Öresund-Kattegat-Skagerrak

Download the brand new 2020 State of Medicon Valley Analysis free of charge

What is the State of the Danish-Swedish life science cluster, Medicon Valley? What is the contribution of life science to the Danish and Swedish economy respectively? How much is life science in Medicon Valley contributing to employment? How does Medicon Valley rank compared to other European life science clusters? What are the obstacles for future development? How to we realise the full potential of the Medicon Valley life science cluster? What is the role of Medicon Valley based life science...

Medicon Valley Alliance certified as GOLD label life science cluster

For the third time, Medicon Valley Alliance passed the “European Cluster exam” with flying colors. The certification, which is conducted by the European Secretariat for Cluster Analysis (ESCA), an institution established by the European Commission, evaluates, and ranks clusters according to for instance strategic and financial leadership, value creation and professionalism, or as it is officially defined by ECSA. “Cluster management organisations holding a GOLD Label show their documented...

The microbiome – a new way to cure diseases and an increasingly stronger research area in Greater Copenhagen

Danish financial daily, Børsen, and, Øresund News, are among the media, which have highlighted the true potential of the  interregional EU project, Greater Copenhagen Microbiome Signature Project led by Medicon Valley Alliance, together with Copenhagen Capacity and Invest in Skåne, with the aim of positioning the life sciences cluster Medicon Valley as a global centre for microbiome research by attracting foreign companies and talent to the region. The project has identified over 80...

Novo Nordisk Scandinavia joins Medicon Valley Alliance

Medicon Valley Alliance is very happy indeed to welcome Novo Nordisk Scandinavia and General Manager & VP, Novo Nordisk Scandinavia, Niels Abel Bonde to the +300 member strong Danish-Swedish MVA-family. "We consider it a strategic priority to be a part of the Swedish and Medicon Valley based life science eco-system. Medicon Valley Alliance is working constructively to create better framework conditions for life science companies in the region, which is something we would also like to...

The Royal Swedish Academy of Sciences awards the Nobel Prize in Chemistry to female genome editing pioneers Emmanuelle Charpentier and Jennifer A. Doudna.

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens, Berlin, Germany and Jennifer A. Doudna, University of California, Berkeley, USA, for their development of a method for genome editing Emmanuelle Charpentier and Jennifer A. Doudna have discovered one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors. Using these, researchers can change the DNA of animals,...

“Think big and pick the low-hanging fruits” – business column by MVA, chairman, Søren Bregenholt, in Copenhagen Post

The COVID-19 outbreak has understandably catapulted healthcare and life science to the very top of the political agenda for at least two different reasons. In today´s Copenhagen Post business column you can read what they are and why and how Medicon Valley, Danish-Swedish life science, and innovation in the Nordics could all benefit, if we think big and pick the low-hanging fruits.

Digital Health – A new Nordic Stronghold

In the print and online magazine, Nordic Business, published this week, MVA Head of Business Development & Public Affairs, David Munis Zepernick, highlights the potential of digital health as a new Nordic life science stronghold. Digital health is a cornerstone of both the newer Danish and Swedish national life science strategies and in the broader public health strategies and Denmark and Sweden, both consistently ranked in the top 10 in virtually any ranking of the use of e-health...